SCM
Stonepine Capital Management Portfolio holdings
AUM
$102M
This Quarter Return
+5.67%
1 Year Return
+40.04%
3 Year Return
+160.28%
5 Year Return
+195.28%
10 Year Return
–
AUM
$191M
AUM Growth
+$191M
(+3.3%)
Cap. Flow
+$9.33M
Cap. Flow
% of AUM
4.88%
Top 10 Holdings %
Top 10 Hldgs %
79.09%
Holding
32
New
3
Increased
11
Reduced
12
Closed
6
Top Buys
| 1 |
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
|
$10.8M |
| 2 |
CHMA
Chiasma, Inc. Common Stock
CHMA
|
$8.65M |
| 3 |
SBBP
Strongbridge Biopharma plc.
SBBP
|
$8.49M |
| 4 |
AMYT
Amryt Pharma plc American Depositary Shares
AMYT
|
$3.32M |
| 5 |
Gyre Therapeutics
GYRE
|
$2.71M |
Top Sells
| 1 |
APEN
Apollo Endosurgery, Inc.
APEN
|
$5.56M |
| 2 |
KalVista Pharmaceuticals
KALV
|
$5.33M |
| 3 |
PLXP
PLx Pharma Inc. Common Stock
PLXP
|
$4.57M |
| 4 |
ADMS
Adamas Pharmaceuticals, Inc.
ADMS
|
$3.82M |
| 5 |
AYTU BioPharma
AYTU
|
$2.76M |
Sector Composition
| 1 | Healthcare | 88.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMYT
1
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
| $33.9M | 17.75% | 2,797,744 +274,016 | +11% | +$3.32M |
|
|
CHMA
2
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $32M | 16.75% | 6,770,000 +1,829,727 | +37% | +$8.65M |
|
|
CTIC
3
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $19.1M | 9.98% | 7,632,530 +4,339,111 | +132% | +$10.8M |
|
|
ADMS
4
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
| $14.2M | 7.44% | 2,694,295 -723,984 | -21% | -$3.82M |
|
|
5
Gyre Therapeutics
GYRE
$703M
| $13.3M | 6.97% | 3,076,376 +626,183 | +26% | +$2.71M |
|
|
SBBP
6
DELISTED
Strongbridge Biopharma plc.
SBBP
| $9.82M | 5.13% | 3,305,617 +2,859,916 | +642% | +$8.49M |
|
7
Ovid Therapeutics
OVID
$91M
| $7.82M | 4.09% | 2,000,000 -483,059 | -19% | -$1.89M |
|
|
CFMS
8
DELISTED
Conformis, Inc. Common Stock
CFMS
| $7.62M | 3.98% | 6,626,085 +2,194,278 | +50% | +$2.52M |
|
|
AFMD
9
DELISTED
Affimed
AFMD
| $7.23M | 3.78% | 850,000 -180,004 | -17% | -$1.53M |
|
|
APEN
10
DELISTED
Apollo Endosurgery, Inc.
APEN
| $6.17M | 3.23% | 762,183 -686,685 | -47% | -$5.56M |
|
11
Xoma
XOMA
$392M
| $5.61M | 2.93% | 165,041 +1,775 | +1% | +$60.3K |
|
12
Celcuity
CELC
$2.17B
| $5.26M | 2.75% | 218,951 +109,870 | +101% | +$2.64M |
|
|
KA
13
DELISTED
Kineta, Inc. Common Stock
KA
| $5.15M | 2.69% | 441,959 +106,214 | +32% | +$1.24M |
|
|
14
KalVista Pharmaceuticals
KALV
$678M
| $4.79M | 2.51% | 200,000 -222,310 | -53% | -$5.33M |
|
|
ISEE
15
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $3.27M | 1.71% | 517,445 -357,735 | -41% | -$2.26M |
|
16
Elicio Therapeutics
ELTX
$172M
| $2.9M | 1.52% | 222,836 +87,852 | +65% | +$1.14M |
|
|
GMDA
17
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
| $2.84M | 1.49% | 443,507 +198,992 | +81% | +$1.28M |
|
18
EyePoint Pharmaceuticals
EYPT
$797M
| $2.73M | 1.43% | 303,851 -25,279 | -8% | -$227K |
|
19
Exagen
XGN
$217M
| $2.54M | 1.33% | 169,542 -21,464 | -11% | -$322K |
|
20
Cidara Therapeutics
CDTX
$1.66B
| $2.45M | 1.28% | +1,211,286 | New | +$2.45M |
|
21
DiaMedica Therapeutics
DMAC
$295M
| $1.87M | 0.98% | 419,942 -603,467 | -59% | -$2.69M |
|
|
CFRX
22
DELISTED
ContraFect Corporation
CFRX
| $296K | 0.15% | 67,208 -201,893 | -75% | -$889K |
|
|
NBSE
23
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
| $149K | 0.08% | +31,070 | New | +$149K |
|
24
Corvus Pharmaceuticals
CRVS
$428M
| $125K | 0.07% | 46,886 -269,393 | -85% | -$718K |
|
|
AGTC
25
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $4K | ﹤0.01% | 1,000 -178,511 | -99% | -$714K |
|